Up a level |
Quraishi, Mohammed Nabil, Dobson, Elizabeth, Ainley, Rachel, Din, Shahida, Wakeman, Ruth, Cummings, Fraser, Sebastian, Shaji, Bloom, Stuart, Limdi, Jimmy K, Dhar, Anjan et al (show 6 more authors)
(2023)
Establishing key performance indicators for inflammatory bowel disease in the UK.
FRONTLINE GASTROENTEROLOGY, 14 (5).
pp. 407-414.
Lovatt, Jessica, Gascoyne-Binzi, Deborah, Hussey, Thomas, Garside, Maya, McGill, Fiona ORCID: 0000-0002-0903-9046 and Selinger, Christian P
(2021)
Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON(R) Gold Testing Useful?
JOURNAL OF CLINICAL MEDICINE, 10 (9).
1816-.
Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg-Bartolo, Simon et al (show 11 more authors)
(2022)
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 55 (7).
pp. 856-866.
Lenti, Marco Vincenzo, Levison, Scott, Eliadou, Elena, Willert, Robert, Kemp, Karen, Carter, Anna, Stansfield, Catherine, Assadsangabi, Arash, Singh, Salil, Crooks, Ben et al (show 13 more authors)
(2018)
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study.
DIGESTIVE AND LIVER DISEASE, 50 (12).
pp. 1299-1304.